Federation des caisses Desjardins du Quebec’s Sionna Therapeutics SION Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio SION Stock Details SION Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.24K	Buy	+210	New	+$8.4K	﹤0.01%	2432

Other funds holding SION

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's SION Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec opened a new position in Sionna Therapeutics (SION) in Q2 2026: 210 shares worth $9.24K. The stake represents ﹤0.01% of the portfolio and ranks #2432 among its holdings.

147 funds tracked by Wall St. Rank hold SION as of Q2 2026.

Federation des caisses Desjardins du Quebec held 210 shares of Sionna Therapeutics worth $9.24K as of Q2 2026.
Sionna Therapeutics was a new Federation des caisses Desjardins du Quebec position in Q2 2026.
Sionna Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2432 holding.
147 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.